Home
Choose language  
Pharmacoreport Pharmacoreport
www.pharmacoreport .com is a news site providing information about the top international pharmaceutical companies. This website will also provide other information about these pharmaceuticals like their address and locations, corporate history, clinical trials, annual report, employees, careers and jobs, health care products, research, sales, shares, dividend & stock price, and patients’ assistance program.
 
AMGen   AMGen

 


AMGen Incorporation is the global biotechnology enterprise which was established in the year 1980. The headquarters of AMGen Inc. are situated at the Newbury Park – the part of Thousand Oaks in California – the United States. The company is supposed to be the biggest autonomous biotechnology enterprise which employs around 15,000 people.

The term AMGen is the combination of the original name of the company which broadly denotes Applied Molecular Genetics which gradually became the formal name of the company during 1983 – precisely 3 years of the company’s incorporation as well as the first ever public offerings inadvertently.  

AMGen is also reported to have strong history of taking over a few of the most leading corporate enterprises such as: Synergen Inc during 1994, Kinetix Pharmaceuticals Inc during 2000, Immunex Corporation during 2002, Tularik Inc during 2004, Abgenix Inc during 2006, Avidia Inc also during 2006, Ilypsa Inc and Alantos Pharmaceuticals Holdings Inc both during the current year i.e. 2007. 

It is reported that for poising as the most future-oriented enterprise, Business Week has AMGen in the 4th position on the S&P 500 on the strength of ratio calculations made apparently on research and development expenses or budgets along with capital spending, and the total outlays by the contenders. AMGen showed the fourth highest ratio figuring as 506:1000. The company is also the member of the Pennsylvania Bio Commerce Organization.

The major products of AMGen include: Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Senispar and Mimpara of which Epogen and Neupogen were the first two biopharmaceutical products of the company when they were launched in the markets. 


Solvey , Elcon , Murk KGaA , Pizer , Biogan Idec , Merk and Co , , Ganentech , Sanophi Aventis , Metsubishi Pharma
Latest News About amgen
Fool.com: Buying Amgen (Rule Breaker Buy Report) December 15, 1998
Therefore itand time for us, something of Amgen gmbh to buying, (Nasdaq: AMGN). ... And now, Amgen. Is what this? are we, who find too many large firms in that of a share, .....More
Amgen Wins Initial Battle In Legal War Over Patent
Through ANDREW pole varnish Amgen, an early won around yesterday in a high stake process... Analyst, that on that deviated become are like significant a victory that this was for Amgen, because.....More
Amgen& Revenue a Little Shy
A year ago Amgen earned $839 million, or 64 cents a share. ... Shares of Amgen were expanded under in trade, recently down $3.61, or 4.6, at $74.48......More
2 Biotechnology Stocks Dive As Nerve Disease Drug Fails
Through LAWRENCE M. FISHERMAN inc. pharmaceutical share by Regeneron and Amgen inc. sharply fell... $2,8125 is Amgen shares, or nearly 5 percent, pleased to $55,0625. .....More
fool.com: Amgen (Dueling Fools) September 22, 1999
Amgen directive biotech (Nasdaq: AMGN) led the medical costs. During we now a better tomato, we canandt grow can, receive you two fools, to agree on what.....More
Amgen chief leads No. 1 biotech firm in transformation - MarketWatch
On the wall of its office at Amgen headquarters, a portrait of the general hangs has... the 55 years CEOand caution old this year as an Amgen, the worldand abbezahlt.....More
Two Drugs in a New Class Pass a Major FDA Hurdle
The new drugs that by two biotechnology firms are developed Amgen inc. and that... Amgen said, received have that 250000 new Krebsepatienten chemotherapy each year.....More
Can Amgen Go Toe-to-Toe with the Big Boys?
If Amgen inc. (AMGN) general director Kevin determined W. Sharer its companyand $16 billions... with its new Anämie drug Aranesp, Amgen tried already to seize share, .....More
AMGEN PLANS TO EXPAND BOULDER CENTER BIOTECH GIANT ASKS CITY FOR...
Meanwhile a group of the scientists that were released by AMGEN formed,... AMGEN expects to adjust at least 100 workers there through the end of this year, .....More
Breaking Out of the Biotech Pack
IF that happens, Amgen will become the second biotechnology firm (Genentech.. Many analysts see now Amgen at - with six other drugs in clinical attempts, .....More